NEW YORK – Illumina said on Monday after the close of the market that it expects first quarter revenues for fiscal year 2021 to grow 26 percent, driven by higher sequencing revenues.
For the three months ended March 31, 2021, the San Diego-based firm expects total revenues of approximately $1.09 billion, up from $859 million in the prior-year period and beating the consensus Wall Street estimate of $945.2 million.